Investors Sell HCP (HCP) on Strength (HCP)
Investors sold shares of HCP, Inc. (NYSE:HCP) on strength during trading on Thursday. $13.73 million flowed into the stock on the tick-up and $25.55 million flowed out of the stock on the tick-down, for a money net flow of $11.82 million out of the stock. Of all stocks tracked, HCP had the 30th highest net out-flow for the day. HCP traded up $0.09 for the day and closed at $22.61
A number of equities research analysts have weighed in on the stock. UBS reissued a “sell” rating and issued a $21.00 price target (down from $25.00) on shares of HCP in a report on Wednesday, February 21st. ValuEngine downgraded shares of HCP from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. JPMorgan Chase & Co. raised shares of HCP from a “neutral” rating to an “overweight” rating and set a $29.00 price target for the company in a report on Friday, December 15th. Jefferies Group reissued a “hold” rating and issued a $26.00 price target on shares of HCP in a report on Tuesday, February 13th. Finally, Stifel Nicolaus reissued a “buy” rating and issued a $27.00 price target (down from $29.00) on shares of HCP in a report on Wednesday, February 14th. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have given a buy rating to the company. HCP presently has a consensus rating of “Hold” and an average price target of $27.50.
The company has a debt-to-equity ratio of 1.23, a quick ratio of 0.31 and a current ratio of 0.31. The firm has a market capitalization of $10,646.98, a P/E ratio of 26.29, a P/E/G ratio of 4.18 and a beta of 0.34.
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 2nd. Shareholders of record on Thursday, February 15th were paid a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a yield of 6.55%. The ex-dividend date was Wednesday, February 14th. HCP’s dividend payout ratio is presently 172.09%.
In related news, insider Kendall K. Young purchased 14,000 shares of HCP stock in a transaction dated Wednesday, February 14th. The stock was acquired at an average cost of $21.91 per share, with a total value of $306,740.00. Following the completion of the transaction, the insider now directly owns 48,544 shares of the company’s stock, valued at $1,063,599.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.22% of the stock is owned by corporate insiders.
Several hedge funds and other institutional investors have recently bought and sold shares of HCP. Cohen & Steers Inc. lifted its position in shares of HCP by 26.6% in the third quarter. Cohen & Steers Inc. now owns 35,762,597 shares of the real estate investment trust’s stock worth $995,273,000 after purchasing an additional 7,524,081 shares in the last quarter. Lasalle Investment Management Securities LLC lifted its position in shares of HCP by 12,329.6% in the fourth quarter. Lasalle Investment Management Securities LLC now owns 6,761,684 shares of the real estate investment trust’s stock worth $176,345,000 after purchasing an additional 6,707,284 shares in the last quarter. Security Capital Research & Management Inc. lifted its position in shares of HCP by 196.4% in the fourth quarter. Security Capital Research & Management Inc. now owns 9,372,788 shares of the real estate investment trust’s stock worth $244,442,000 after purchasing an additional 6,210,806 shares in the last quarter. Brookfield Asset Management Inc. purchased a new stake in shares of HCP in the fourth quarter worth approximately $150,605,000. Finally, PGGM Investments lifted its position in shares of HCP by 41.2% in the fourth quarter. PGGM Investments now owns 8,013,000 shares of the real estate investment trust’s stock worth $208,979,000 after purchasing an additional 2,336,126 shares in the last quarter. 88.48% of the stock is owned by institutional investors and hedge funds.
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.